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This brief review examines the history of the use of creatinine as a measure of renal function. While there are more accurate markers of glomerular filtration, creatinine was chosen for convenience. Since the relationship of creatinine to glomerular filtration depends upon a tenuous balance of counterbalancing factors, practitioners should be alert to situations that alter that balance. While the averaging of variations over time helps to avoid some of the problems with diurnal variations in the past, the present-day reliance upon equations based upon a solitary serum value is likely to amplify those problems in clinical situations when the effect of disease, medications, diet and time of day upon that balance are not considered.
Ann Clin Biochem 2007; 44: [16] [17] [18] [19] The kidneys have a wide spectrum of physiological functions, but despite this plasma ¢ltration is the function for which the kidney is predominantly noted. Separation of the glomerular ¢ltrate from the blood is merely the result of ultra¢ltration of water and its solutes (excluding macromolecules). That process is known as glomerular ¢ltration and its rate is measured by multiplication of the permeability constant of the glomerular basement membrane (K f ) by the sum of the hydrostatic pressure di¡erence (DP) across that membrane minus the colloid oncotic pressure (DP) di¡erence and is expressed as the equation: glomerular ¢ltration rate (GFR) ¼ K f (DP--DP).
Since we have no direct knowledge of the rate that the water passes per se, we need to measure GFR in terms of a reference substance. Early 20th century investigators agreed that an accurate marker for GFR should be: (1) completely ¢ltered at the glomerulus, (2) free from synthesis or secretion by the tubules, (3) free from reabsorption by the tubules and (4) physiologically inert. 1 Of all the substances that were investigated, inulin, a polysaccharide of molecular weight of approximately 5000 Da, met all those goals, but it was inconvenient because it required a timed urine collection and the administration of an exogenous substance 1 by specialized technical personnel. Urea was the most well-known endogenous urinary waste product (and even shared the same Latin root, urina), but although it was ¢ltered by the glomerulus similarly to inulin, it was highly di¡usible and, depending upon the concentration gradient, would di¡use passively out of the tubule and into the renal interstitium at di¡erent levels of the nephron. 2 Urea, therefore, was unacceptable. Creatinine, a metabolic product from the breakdown of creatine phosphate in muscle, was not considered an obvious alternative. Oddly enough, when Rehberg ¢rst proposed the use of creatinine, it was also as an exogenous administration. 3 Endogenous creatinine was not considered to be su⁄ciently reliable because there were many substances (acetate, pyruvate, ascorbic acid, barbiturate) 4 in the serum that also gave a positive Ja¡e reaction. When serum values were less than 88 mmol/L, the Ja¡e reaction overestimated true creatinine by as much as 90%, although that percentage fell to a mere 21% for higher values. 5 The introduction of the Folin--Wu method solved many of the problems of overestimation, 6 but there remained another serious problem with creatinine that was considered as an exclusion criterion as a substance to measure GFR. While there is no tubular secretion of creatinine in goose¢sh, toad¢sh, dog¢sh and chickens, there is tubular secretion of creatinine in man that was estimated to be about 28%. 7 However, an adaptation of the Ja¡e reaction for the introduction of the automated chemical autoanalyzer reduced the overestimation of true creatinine to just 21%. 5 Since that 21% overestimation often counterbalanced the tubular secretion, a marriage of convenience was born, because the measurement of an endogenous creatinine clearance did not require the inconvenience of the administration of an exogenous substance.
Creatinine clearance (Ccr) was thus calculated by dividing the product of the urine concentration of creatinine (Ucr) and its volume (Vcr) by the product of the serum creatinine (Scr) and the number of minutes (T) in which the urine specimen had been collected:
Creatinine clearance still required the inconvenience of a timed urine collection. Unfortunately, patients often could not be relied upon in outpatient settings to accurately collect all of their urine samples and often collections would need to be re-started when urine was lost during defaecation. Therefore, attempts were made to shorten the collection time for convenience and hopefully to improve accuracy. This attempt is undermined by the inconstant production of creatinine. Physical activity, 8 fever 9 and dietary intake are all capable of producing signi¢cant variations in the serum creatinine. Although raw meat contains mostly creatine and very little creatinine, exposure to high temperatures vastly increases the amount of creatinine. Canned meat has large amounts of creatinine 10 and the consumption of well-cooked steak can signi¢cantly increase serum creatinine. 11 Therefore, time averaging of those variations was thought necessary. Diurnal variations of creatinine also occur. Creatinine clearance increases in hours of deepest sleep 12 and serum creatinine is 11% higher in non-fasting subjects in afternoon hours. 13 Therefore, collection times of less than 24 h may be subject to greater variations than 24 h collections.
Although it was evident that a linear relationship did not exist between serum creatinine and creatinine clearance, several attempts were made to develop mathematical relationships to estimate clearance from a solitary serum creatinine. 14 that was developed to predict creatinine clearance from serum creatinine in men (with a 15% adjustment for women). The authors developed the relationship based upon data from 249 patients aged 18--92 years. The results from the formula were compared with the means of two measurements of 24-h creatinine clearance in 236 patients. The above formula gave a correlation coef-¢cient between predicted and mean measured creatinine clearance of 0.83; on average, the di¡erence between predicted and mean measured values was no greater than that between paired clearances. It must be noted, however, that the authors never intended their formula to predict GFR, but merely to estimate creatinine clearance.
Eventually, micropuncture studies con¢rmed that the glomerulus was freely permeable to inulin whereas the tubule wall was impermeable, unlike endogenous creatinine with its tubular secretion. 16 By that time, it was widely recognized that creatinine was indeed an inadequate measure of GFR. 17 We had come to realize that not only were there problems with tubular secretion and non-creatinine chromogens, but that extrarenal elimination can also occur. In acute renal failure, the serum creatinine increases in direct proportion to that retained in the body. 18 In chronic renal failure, the daily increase in serum creatinine is only one-half to one-third of the expected increase from any given fall in GFR. 19 At normal serum concentrations, the amount of creatinine entering the gut is negligible but as the serum creatinine rises it becomes signi¢cant. 18 The bacterial proliferation that then develops in the upper gastrointestinal tract in chronically uraemic patients then plays an important role in the induction of the creatinase system. Metabolites of creatinine can then be found in the faeces, plasma, urine and expired air of uraemic patients. 18 It is estimated that from 16% to 66% of creatinine formed is excreted extrarenally in the uraemic patient. 19 Recently some have found cystatin C to be a better marker of GFR, and cystatin C-based prediction equations appear more accurate than creatinine-based equations. 20 Yet, we continued to use creatinine because it was convenient and by the 1980s we had had so much experience with it that we really knew more about human diseases and symptoms at any given creatinine clearance than at the true GFR. In reality, we do not use creatinine clearance to estimate GFR, since we have so little experience with real inulin clearances, but we use it because we have become comfortable with creatinine and have such a vast experience with creatinine clearances that we can better predict symptoms at a known creatinine clearance than we could if we had an inulin clearance. Some investigators therefore suggested that rather than try to estimate GFR by creatinine clearances, we would do just as well using serum creatinine to follow the changes in renal function, 21 but as noted above there are signi¢cant daily variations in serum creatinine concentrations. This will lead to a variation in observed values, and a measurement that accounted for a time averaging of those variations was thought to produce a more representative value for any given individual.
Nevertheless, attempts to ¢nd more convenient ways to use creatinine continued. During the feasibility phase of the Modi¢cation of Diet in Renal Disease (MDRD) Study, a multicentre, controlled trial of predominantly white non-diabetics to determine the e⁄cacy of low-protein diets in patients with progressive renal disease, it was agreed that the rate of change in reciprocal of the plasma creatinine (1/PCr) was not an accurate index of the rate of change in GFR. The authors suggested that such an inaccuracy raised questions about the validity of conclusions from previous studies in which the e⁄cacy of dietary modi¢cation in retarding the progression of renal disease was based Ann Clin Biochem 2007; 44: [16] [17] [18] [19] principally on measurements of 1/PCr. 22 As noted above, this was in reality already known. As a result, GFR was measured by I 125 iothalamate and, despite a high intra-test coe⁄cient of variation, it was thought an acceptable measure. 23 The MDRD study group then developed a new equation by multivariate regression analysis back to those iothalamate clearances: 24 GFR¼170ÂPcr À0.999 Âage À0.176 Â(0.762 if patient is female)Â(1.180 if patient is black)ÂSUN À0.170 Âalb 0.318
Although the equation continued to rely heavily upon the reciprocal of the serum creatinine and age with a minor adjustment for sex, this equation was thought by many to have many advantages over the Cockcroft--Gault equation due to the inclusion of factors such as the serum urea nitrogen (SUN), race and serum albumin (alb). Unlike the Cockcroft--Gault equation, however, the proponents of the MDRD equation claimed to be an estimate of GFR despite its reliance upon creatinine. As a result, many organizations promoted the use of this equation in public health policy since the concept of GFR was easier for many physicians to understand and most de¢nitely more convenient for patients to collect than creatinine clearance. Using this equation, public health campaigns could focus on messages such as 'Know your number'or 'Save your GFR,'a strategy analogous to that used for hypertension or hyperlipidaemia. 25 Furthermore, elimination of the urinary collection also reduced the costs of third-party payers. As a result, many organizations began to require clinical laboratories to report a serum creatinine as an estimated GFR and some experts no longer recommended urinary collections. 26 Unfortunately, notwithstanding the public policy, many reports began to surface reporting problems with the MDRD equation in di¡erent ethnic groups, assays and at di¡erent levels of renal function, with the result that the authors therefore felt compelled to propose new equations based upon the reciprocal of the serum creatinine that were claimed to be more'accurate'. 27--40 This seems to propound the fallacy that a creatinine-based equation exists that really predicts GFR.
Unfortunately, anything that interferes with the tenuous balance of creatinine secretion and non-creatinine chromogens will result in major miscalculations of GFR. All equations will misinterpret a patient with ketoacidosis 41 or IgM myeloma 42 as su¡ering a loss in GFR and another with hyperbilirubinaemia 43 as demonstrating an improvement in function where there is in reality no such loss or improvement, but rather re£ects an analytical error in the measurement of serum creatinine. Administration of medications such as trimethoprim, 44 cimetidine 45 or feno¢brate 46 will similarly be interpreted by those equations as a loss in GFR rather than the changes in tubular secretion or creatinine production that they really are. Furthermore, published clinical studies of dopamine or dobutamine in heart failure have used creatininebased equations to demonstrate a bene¢cial e¡ect on renal function with a gain in GFR when it is really only interference with the Ja¡e reaction. 47 Since many of the studies that have evaluated the use of acetylcysteine to prevent contrast nephrotoxicity have only collected serum creatinine to estimate clearance, it may be that the 'protective'e¡ect is also another example of analytical interference.
Diurnal variations, medications and metabolic states need always to be considered when using creatinine to estimate renal function.
The National Kidney Foundation in collaboration with international professional organizations recently attempted to improve the accuracy and standardization of creatinine methods worldwide to avert some of the problems. 48 Unfortunately, the problem is not with one particular equation, assay or ethnic group. The problem is, and has always been, with creatinine itself and our own search for convenience. Creatinine clearance is not and has never been synonymous with GFR and no regression analysis will make it so because the serum creatinine depends upon many other factors than ¢ltration. We should not be surprised that the more approximations that we make, the less accurate our data become. The problems come when we actually delude ourselves (and others) into thinking that these equations actually represent a true measure of GFR.
